Insufficiency Fractures after Pelvic Radiotherapy for Uterine Cervical Cancer: An Analysis of Subjects in a Prospective Multi-institutional Trial, and Cooperative Study of Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG)

Insufficiency Fractures After Pelvic Radiation Therapy for Uterine Cervical Cancer: An Analysis of Subjects in a Prospective Multi-institutional Trial, and Cooperative Study of the Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.03.042 ◽

2012 ◽

Vol 84 (2) ◽

pp. e195-e200 ◽

Cited By ~ 46

Author(s):

Sunao Tokumaru ◽

Takafumi Toita ◽

Masahiko Oguchi ◽

Tatsuya Ohno ◽

Shingo Kato ◽

...

Keyword(s):

Cervical Cancer ◽

Radiation Therapy ◽

Radiation Oncology ◽

Uterine Cervical Cancer ◽

Study Group ◽

Insufficiency Fractures ◽

Cooperative Study ◽

Oncology Group ◽

Pelvic Radiation ◽

Prospective Multi-institutional Study of Definitive Radiotherapy with High-dose-rate Intracavitary Brachytherapy in Early Stage Uterine Cervical Cancer: A Cooperative Study of Japan Radiation Oncology Group (JAROG) and Japanese Radiation Oncology Study Group (JROSG)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2010.07.305 ◽

2010 ◽

Vol 78 (3) ◽

pp. S120

Author(s):

T. Toita ◽

S. Kato ◽

Y. Niibe ◽

T. Kazumoto ◽

T. Kodaira ◽

...

Keyword(s):

Radiation Oncology ◽

Early Stage ◽

Uterine Cervical Cancer ◽

High Dose Rate ◽

Intracavitary Brachytherapy ◽

High Dose ◽

Study Group ◽

Cooperative Study ◽

Oncology Group ◽

Individualized Prediction of Overall Survival After Postoperative Radiation Therapy in Patients With Early-Stage Cervical Cancer: A Korean Radiation Oncology Group Study (KROG 13-03)

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2013.07.020 ◽

2013 ◽

Vol 87 (4) ◽

pp. 659-664 ◽

Cited By ~ 9

Author(s):

Hyun Jin Lee ◽

Seungbong Han ◽

Young Seok Kim ◽

Joo-Hyun Nam ◽

Hak Jae Kim ◽

...

Keyword(s):

Cervical Cancer ◽

Radiation Oncology ◽

Early Stage ◽

Oncology Group ◽

Postoperative Radiation ◽

Postoperative Radiation Therapy ◽

Oncology Group Study ◽

Early Stage Cervical Cancer ◽

Individualized Prediction

Patterns of definitive radiotherapy practice for cervical cancer in South Korea: a survey endorsed by the Korean Radiation Oncology Group (KROG 20-06)

Journal of Gynecologic Oncology ◽

10.3802/jgo.2021.32.e43 ◽

2021 ◽

Vol 32 ◽

Author(s):

Nalee Kim ◽

Won Park

Keyword(s):

Cervical Cancer ◽

South Korea ◽

Radiation Oncology ◽

Oncology Group ◽

Definitive Radiotherapy ◽

Comparison Between the German Hodgkin Study Group (GHSG) Involved Field Radiation Therapy (IF-RT) Versus the International Lymphoma Radiation Oncology Group (ILROG) Involved Site Radiation Therapy (IS-RT) for Patients with Hodgkin Lymphoma- Is ISRT the New Standard?

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2014.05.632 ◽

2014 ◽

Vol 90 (1) ◽

pp. S153

Author(s):

J. Kriz ◽

U. Haverkamp ◽

S. Frick ◽

H.T. Eich

Keyword(s):

Radiation Therapy ◽

Hodgkin Lymphoma ◽

Radiation Oncology ◽

Study Group ◽

Oncology Group ◽

German Hodgkin Study Group ◽

Field Radiation ◽

Involved Field

Faculty Opinions recommendation of Phase II trial of paclitaxel and nedaplatin in patients with advanced/recurrent uterine cervical cancer: a Kansai Clinical Oncology Group study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717948619.793453725 ◽

2012 ◽

Author(s):

David Kushner ◽

Shitanshu Uppal

Keyword(s):

Cervical Cancer ◽

Clinical Oncology ◽

Phase Ii ◽

Phase Ii Trial ◽

Uterine Cervical Cancer ◽

Oncology Group ◽

Oncology Group Study

Modern Radiation Therapy for Primary Cutaneous Lymphomas: Field and Dose Guidelines From the International Lymphoma Radiation Oncology Group

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2015.01.008 ◽

2015 ◽

Vol 92 (1) ◽

pp. 32-39 ◽

Cited By ~ 75

Author(s):

Lena Specht ◽

Bouthaina Dabaja ◽

Tim Illidge ◽

Lynn D. Wilson ◽

Richard T. Hoppe

Keyword(s):

Radiation Therapy ◽

Radiation Oncology ◽

Oncology Group ◽

Cutaneous Lymphomas ◽

Corrigendum to “HPV16 DNA status is a strong prognosticator of loco-regional control after postoperative radiochemotherapy of locally advanced oropharyngeal carcinoma: Results from a multicentre explorative study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)” [Radiother. Oncol. 113 (2014) 317–323]

Radiotherapy and Oncology ◽

10.1016/j.radonc.2015.03.010 ◽

2015 ◽

Vol 114 (3) ◽

pp. 419

Author(s):

Fabian Lohaus ◽

Annett Linge ◽

Inge Tinhofer ◽

Volker Budach ◽

Eleni Gkika ◽

...

Keyword(s):

Radiation Oncology ◽

Locally Advanced ◽

Oropharyngeal Carcinoma ◽

Oncology Group ◽

Regional Control ◽

Explorative Study ◽

Postoperative Radiochemotherapy

Modern Radiotherapy for Extranodal Nasal-type NK/T-cell Lymphoma: Risk-adapted Therapy, Target Volume and Dose Guidelines from the International Lymphoma Radiation Oncology Group

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2021.02.011 ◽

2021 ◽

Author(s):

Shu-Nan Qi ◽

Ye-Xiong Li ◽

Lena Specht ◽

Masahiko Oguchi ◽

Richard Tsang ◽

...

Keyword(s):

T Cell ◽

Radiation Oncology ◽

Cell Lymphoma ◽

Target Volume ◽

Oncology Group ◽

Nasal Type ◽

Therapy Target ◽

Modern Radiotherapy ◽

Lymphoma Risk

A Randomised Phase III Trial of Palliative Radiotherapy (PRT) versus Concurrent Chemotherapy and PRT (C-PRT) in Patients with Good Performance Status, Locally Advanced or Metastatic NSCLC with symptoms due to intrathoracic disease who are not suitable for radical Chemo-radiotherapy: Results of the Trans-Tasman Radiation Oncology Group (TROG) 11.03 Trial

Practical Radiation Oncology ◽

10.1016/j.prro.2020.11.009 ◽

2020 ◽

Author(s):

M. Lehman ◽

A. Bernard ◽

A. See ◽

M. King ◽

M. Michael

Keyword(s):

Radiation Oncology ◽

Performance Status ◽

Locally Advanced ◽

Palliative Radiotherapy ◽

Concurrent Chemotherapy ◽

Phase Iii ◽

Oncology Group ◽

Phase Iii Trial ◽

Metastatic Nsclc ◽